Publications

<

Year: 2023

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants

Published on: Vaccines (Basel)
Authors: Sophie Warren, Myrto Barmpouni, Vasiliki Kossyvaki, George Gourzoulidis, Johnna Perdrizet,

Abstract: In June 2010, Greece introduced the 13-valent pneumococcal conjugate vaccine (PCV13) for pediatric vaccination and has since observed a large decrease in pneumococcal disease caused by these vaccine serotypes, yet the disease prevalence of non-vaccine...

Read More

Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece

Published on: Value in Health Regional Issues
Authors: Charalampos Tzanetakos, George Gourzoulidis,

Abstract: Objectives: This study aimed to systematically review the use of cost-effectiveness (CE) threshold for evaluating pharmacological interventions in Greece. Methods: A systematic search of PubMed and ScienceDirect was conducted between January 2009 and June...

Read More

Archive per Year